EFFICACY OF DESENSITIZATION THERAPY FOR ALLERGY TO FACTOR IX CONCENTRATES-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EFFICACY OF DESENSITIZATION THERAPY FOR ALLERGY TO FACTOR IX CONCENTRATES

Published:2022-06-24 Issue:3 Volume:68 Page:422-427
ISSN:1881-3011
Container-title:Japanese Journal of Transfusion and Cell Therapy
language:en
Short-container-title:JJTC

Author:

Suzuki Nobuaki¹,Kanematsu Takeshi²,Kishimoto Mayuko²,Suzuki Naruko³,Okamoto Shuichi²,Tamura Shogo⁴,Kiyoi Hitoshi³,Matsushita Tadashi¹

Affiliation:

1. Department of Transfusion Medicine, Nagoya University Hospital

2. Department of Clinical Laboratory, Nagoya University Hospital

3. Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

4. Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine

Publisher

Japan Society of Transfusion Medicine and Cell Therapy

Subject

Computer Networks and Communications,Hardware and Architecture,Software

Link

https://www.jstage.jst.go.jp/article/jjtc/68/3/68_422/_pdf

Reference15 articles.

1. 1) Roth DA, Kessler CM, Pasi KJ, et al: Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates. Blood, 98 (13): 3600-3606, 2001.

2. 2) Shapiro AD, Di Paola J, Cohen A, et al: The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. Blood, 105 (2): 518-525, 2005.

3. 3) Monahan PE, Liesner R, Sullivan ST, et al: Safety and efficacy of investigator-prescribed BeneFIX prophylaxis in children less than 6 years of age with severe haemophilia B. Haemophilia, 16 (3): 460-468, 2010.

4. 4) Recht M, Pollmann H, Tagliaferri A, et al: A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B. Haemophilia, 17 (3): 494-499, 2011.

5. 5) Berntorp E, Keeling D, Makris M, et al: A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use. Haemophilia, 18 (4): 503-509, 2012.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3